Business
LivaNova Elects Peter Wilver to Board of Directors
LONDON--(BUSINESS WIRE)-- LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, today announced Peter Wilver has been
About this update from Livanova Plc
[{"type":"text","content":" LONDON--(BUSINESS WIRE)--\nLivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, today announced Peter Wilver has been elected to the Board of Directors, effective immediately. His election was part of the LivaNova 2022 Annual General Meeting of Shareholders (AGM) held on June 13.\n\nWilver joins the LivaNova Board with more than 30 years of business experience. He retired from Thermo Fisher Scientific, Inc., a provider of laboratory products and services, in 2017 after serving as the company’s Executive Vice President and Chief Administrative Officer since 2015, as well as Senior Vice President and Chief Financial Officer from 2006-2015. He served as Thermo Electron’s Vice President and Chief Financial Officer from 2004-2006, having previously been Vice President, Financial Operations from 2000-2004. Throughout his career, he held financial leadership roles at Honeywell International, Grimes Aerospace Company and General Electric Company. Other public company directorships in the past five years include Evoqua Water Technologies Corporation (current), Shoals Technology Group (current), CIRCOR International, Inc. and Tenet Healthcare Corporation.\n\n“Pete offers a wealth of strategic planning, business development and financial experience with large, multinational manufacturing companies that will bring additional acumen to our accomplished Board of Directors,” said William Kozy, LivaNova Board Chair. “The Board welcomes Pete and looks forward to his engagement and contributions.”\n\nWilver joins eight other professionals who were re-elected to their Board seats.\n\nAbout LivaNova\n\nLivaNova PLC is a global medical technology and innovation company built on nearly five decades of experience and a relentless commitment to provide hope for patients and their families through innovative medical technologies, delivering life-changing improvements for both the Head and Heart. Headquartered in London, LivaNova employs approximately 3,000 employees and has a presence in more than 100 countries for the benefit of patients, healthcare professionals and healthcare systems worldwide. For more information, please visit www.livanova.com.\n\nSafe Harbor Statement\n\nThis news release contains “forward-looking statements” concerning the Company’s goals, beliefs, expectations, strategies, objectives, plans a...